The Babraham Institute undertakes world-leading research into understanding the biology of how our bodies work, including what changes as we age and during disease. Our research is split into three programmes: Epigenetics, Signalling, and Lymphocyte Signalling, supported by strategic programme grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and additional funding from research councils, the EU and charities.

We maximise the impact of our research through Knowledge Exchange, Commercialisation and Public Engagement activities. We do this by collaborating with other academics, policy makers, charities, schools, the general public and industry, including companies on the Babraham Research Campus. Commercialisation is achieved in collaboration with the Institute’s wholly-owned trading arm, Babraham Institute Enterprise Limited.

 


14/09/2020

Institute looks to appoint new Trustees

Board of Trustees vacancies

Provide support, expertise and leadership to guide the Institute's development


14/09/2020

Institute signalling research waves red flag for commercial drug target candidate

Research identifies unintended effects

Findings will prevent wasted effort in drug target development


07/09/2020

Improving European healthcare through cell-based interceptive medicine

LifeTime roadmap and perspective published

Presenting a vision of how to revolutionise healthcare


07/09/2020

Institute announces new Epigenetics and Signalling research programme leaders

Senior scientists become programme heads

Gavin Kelsey and Simon Cook will head the Epigenetics and Signalling programmes respectively

Access our Science Services

Bioinformatics
Imaging
Sequencing
Biological Support Unit
Lipidomics
Biological Chemistry
Flow Cytometry
Mass Spectrometry
Gene Targeting
Bioinformatics

Providing comprehensive tools and analysis for life sciences Key services Bioinformatics Analysis Consultancy Statistics Training Software Infrastructu

Imaging

The Imaging Facility provides a high quality microscopy and image analysis service, enabling scientists to use advanced imaging methods in their research. We provide trai

Sequencing

Next Generation Sequencing technology has revolutionised post-genomics studies of gene expression, genetic regulation and nuclear dynamics. The Sequencing Facility provid

Biological Support Unit

Our state-of-the-art Biological Support Unit provides housing and care for pathogen-free rodents. It supports research across the Institute as well as providing services

Lipidomics

The Lipidomics facility uses chromatographic techniques coupled to tandem mass-spectrometry instruments to study a wide range of chemical species including neutral, phosp

Biological Chemistry

To provide a research interface between chemistry and biology to solve biological questions. Key services Chemical synthesis (bio-active molecules, fluorescent or i

Flow Cytometry

The Babraham Institute Flow Cytometry Core Facility offers high quality service and state-of-the-art instrumentation to members of Babraham Institute and external users.

Mass Spectrometry

The primary role of the Facility is to apply state of the art techniques in mass spectrometry to address important biological questions, within the remit of the Institute

Gene Targeting

To deliver gene targeting capabilities including the production of transgenic mouse models. Key services Generation of mouse models; ranging from single nucleoti


No Upcoming Seminars Currently


No Upcoming Events Currently

 

Key visitor pages

Members of the public may wish to look at the following pages to find out how the Babraham Institute works with and for society:

The following pages may be of particular interest to those in the Academic community:

Members of the media and journalists may wish to visit the following sections for further details about our work:


Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease.

Rönkkö J, Molchanova S, Revah-Politi A,

Annals of clinical and translational neurology
1 1: 19 Sep 2020

PMID: 32949214

Profiling DNA Methylation Genome-Wide in Single Cells.

Galvão A, Kelsey G,

Methods in molecular biology (Clifton, N.J.)
2214 1: 2021

PMID: 32944913

Inflammatory aortitis in a patient with type 2 hyper IgM syndrome.

Staels F, Betrains A, Willemsen M,

Rheumatology (Oxford, England)
1 1: 17 Sep 2020

PMID: 32940674

Of Mosaicism and Mechanisms: How JAK1 Goes Awry.

Ross SH, Cantrell DA,

Immunity
53 3: 15 Sep 2020

PMID: 32937149